Format

Send to

Choose Destination
See comment in PubMed Commons below
J Med Ethics. 2009 Aug;35(8):469-70. doi: 10.1136/jme.2009.030460.

Expectations regarding cognitive enhancement create substantial challenges.

Author information

1
Neuroethics Research Unit, Institut de recherches cliniques de Montréal, Department of Medicine, Université de Montréal, and Department of Neurology and Neurosurgery & Biomedical Ethics Unit, McGill University, Montréal, Canada. eric.racine@ircm.qc.ca

Abstract

A recent discussion on cognitive enhancers has caused some controversy in the ethics and neuroscience fields by coming out in favour of making neuropharmaceuticals with enhancing properties available for general consumption. We highlight in this brief commentary why concerns regarding efficacy and safety, demands on resources, and public health are substantive enough to warrant serious reconsideration before pharmaceutical performance enhancement can be widely supported.

PMID:
19644002
DOI:
10.1136/jme.2009.030460
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center